TAVALISSE FDA approval date
The FDA approved TAVALISSE on 17 Apr 2018.
- FDA approval date
- 17 Apr 2018
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as FOSTAMATINIB DISODIUM
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2018-04-17Day | TAVALISSE | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA209299", "applicant_as_listed_by_fda": "RIGEL PHARMS", "brand_names": ["TAVALISSE"], "active_ingredients": ["FOSTAMATINIB DISODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180417", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |